HDAC9 and cancer: HDAC inhibitors (HDACis) exhibit antitumor effects by activating cell cycle arrest, inducing apoptosis and autophagy, inhibiting angiogenesis, and increasing the generation of reactive oxygen species to induce oxidative stress, which all contribute to cancer cell death [5,6].